Sigachi Industries Ltd

AGM Details

• Date and time: 15 September 2026, 11:00 AM.
• Mode: VC / OAVM.
• Record date / e-voting cut-off: 08 September 2026.
• Deemed venue: Registered Office.

Resolutions

• Item 1 (Ordinary): Increase authorised share capital and amend Capital Clause in MOA.
• Item 2 (Special): Issue up to 11,00,00,000 convertible warrants on preferential basis.
• Warrant price: Rs 26.40 per warrant; aggregate value up to Rs 290.40 crore.
• Objects: API expansion, working capital, general corporate purposes.
• Allocation breakdown: promoter 7.50 crore; non-promoter 3.50 crore.
• Pricing reference: Relevant Date 14 Aug 2026; price Rs 26.40.
• Post-issue shareholding patterns disclosed for promoters and non-promoters.
• Conditions: listing, private placement, and approvals per ICDR Regulations.

Voting Status

• Voting results not available in this notice.
• Remote e-voting window: 11.09.2026 to 14.09.2026.

Disclosures & Other

• Objects financing: API expansion, working capital, general corporate purposes.
• Post-issue, shareholding patterns and lock-in requirements applicable under ICDR regulations.

Annexure A correction

• Typographical error corrected: Allottee at Sl.34 now 'K Neelima' instead of 'Anil Kondoth'.
• Other details in the board outcome and Annexure A remain unchanged.

Internal Audit Changes

• PRSV & Co. LLP resigned as Internal Auditors for FY 2026-27, effective 22 August 2026.
• RSM Astute Consulting Pvt Ltd appointed Internal Auditors for FY 2026-27, effective 22 August 2026.
• RSM Astute Consulting Pvt Ltd is part of RSM International with Pan-India presence in 12 cities.

Financial Performance

• Q1 FY27: Total operating income INR121.27 cr; EBITDA INR16.5 cr; PAT INR8.14 cr.
• EBITDA margin 13.6%; PAT margin 6.76%.
• MCC revenue INR82.74 cr; O&M INR13.06 cr; API INR21.68 cr.
• Realization per kg INR241.36; Q4 realization INR216.
• Receivables days around 93-94; target 90 by year-end.
• Company debt-free; no term loan currently.

Operations & Segment Update

• MCC capacity expansion: 12,000 MT at Dahej-2; commissioning by Q2 FY28.
• Total cellulose capacity to 30,000 MT.
• Dahej SEZ CCS facility 1,800 MT advancing.
• HiCel SMCC Nutra launched; higher-value excipients.
• API growth: Sparsentan and Bempedoic acid; INR21 cr in Q1.
• CCS export demand rising; margins linked to exports.

Capex & Projects

• FY27 capex guidance: > INR100 cr; FY28 capex: INR150-200 cr.
• Dahej 2 expansion timeline: FY28 Q2 completion; earlier Q4 FY27.
• Insurance claim: settlement by September; INR16.5 cr expected.
• Funding options: internal accruals; borrowings; possible preferential equity; announcements later.
• CCS orders from export customers; market demand strengthening.

Guidance & Outlook

• Revenue guidance INR650-675 cr; on track; Q2 onwards growth.
• Full-year EBITDA margin guidance: 18%.

Q&A Highlights

• MCC realization rose to INR241.36/kg vs INR216/kg last quarter.
• Capacity shortfall caused 6,000 MT loss; expect regain as capacity returns.
• API ramp: INR21 cr in Q1; guided INR100-110 cr in coming quarters.
• Dahej expansion delayed to FY28 Q2; funding via internal accruals or preferential equity.
• Insurance settlement timing remains key; September settlement possible; INR16.5 cr expected.
• Receivables days target 90 by year-end; then 75-80 thereafter.

Balance Sheet & Cash Flow

• Debt-free status; no term loan currently; potential future borrowings discussed.
• Receivables days currently 93-94; plan to reduce to 90 by year-end.

Meeting Details

• Date: August 22, 2026; via Video Conference.

Key Agenda Items

• Proposal to raise funds via preferential issue of equity shares/convertibles to promoters and non-promoters, subject to approvals.

Other Notes

• Trading window closed from 19 August 2026 for 48 hours post-board meeting for designated persons and connected persons.

Issue overview

• Monitoring Agency Report dated August 13, 2026 on IPO proceeds utilization for the quarter ended June 30, 2026.